Antimicrobial Drugs

Introduction to Antimicrobial Drugs

Antimicrobial drugs are agents that interfere with the growth of microbes within a host organism. They are essential tools in the treatment of infectious diseases caused by bacteria, fungi, protozoa, and helminths.

• Antimicrobial drugs: Compounds that inhibit or kill microorganisms without causing significant harm to the host.

• Paul Ehrlich: Introduced the concept of the "magic bullet"—a drug that targets pathogens without harming the host. He developed Salvarsan, an early antimicrobial agent, and coined the term chemotherapy (the use of chemicals to treat disease).

• Selective toxicity: The ability of a drug to target harmful microbes specifically, sparing host cells.

Discovery of Antibiotics

The discovery of antibiotics revolutionized the treatment of bacterial infections.

• Alexander Fleming (1928): Discovered penicillin, the first true antibiotic, produced by the mold Penicillium.

• Antibiotic: A substance produced by a microbe that, in small amounts, inhibits the growth of another microbe.

Problems of Chemotherapy for Different Infections

Challenges in Treating Various Pathogens

The effectiveness and safety of antimicrobial drugs depend on the type of pathogen being targeted.

• Bacterial infections: Easier to treat because bacteria are prokaryotic and differ significantly from human cells.

• Fungal, protozoan, and helminthic infections: More difficult to treat due to the eukaryotic nature of these organisms, which are more similar to human cells, increasing the risk of host toxicity.

• Viral infections: Particularly challenging because viruses replicate inside host cells and use the host's cellular machinery, making selective targeting difficult.

Key Terms

Definitions

• Spectrum of activity: The range of different microbes against which an antimicrobial agent is effective.

• Narrow-spectrum antibiotic: Effective against a limited group of microorganisms (e.g., only Gram-positive bacteria).

• Broad-spectrum antibiotic: Effective against a wide variety of microorganisms, including both Gram-positive and Gram-negative bacteria.

• Superinfection: The growth of a pathogen that has developed resistance to an antibiotic, often resulting in an opportunistic infection.

Sources of Antibiotics

Representative Sources and Examples

Antibiotics are derived from various microorganisms, including bacteria and fungi.

Modes of Action of Antimicrobial Drugs

Overview of Mechanisms

Antimicrobial drugs target specific structures or functions in microbial cells, leading to their inhibition or death.

• Inhibition of cell wall synthesis: Prevents bacteria from forming a functional cell wall (e.g., penicillins, cephalosporins, vancomycin).

• Inhibition of protein synthesis: Interferes with ribosomal function, blocking translation (e.g., chloramphenicol, tetracyclines, streptomycin).

• Inhibition of nucleic acid synthesis: Blocks DNA replication or transcription (e.g., rifamycins, quinolones).

• Injury to plasma membrane: Disrupts membrane integrity, causing cell lysis (e.g., polymyxin B, lipopeptides).

• Inhibition of essential metabolite synthesis: Blocks metabolic pathways (e.g., sulfonamides inhibit folic acid synthesis).

Examples of Drug Classes and Their Actions

• Penicillins: Inhibit cell wall synthesis by blocking peptidoglycan cross-linking. Contain a β-lactam ring structure.

• Cephalosporins: Similar to penicillins but with a broader spectrum and resistance to some β-lactamases.

• Vancomycin: Glycopeptide antibiotic, important as a last-resort drug against resistant Gram-positive bacteria (e.g., MRSA).

• Isoniazid (INH): Inhibits mycolic acid synthesis in mycobacteria (e.g., tuberculosis).

• Rifamycins: Inhibit mRNA synthesis; used for tuberculosis and leprosy.

• Quinolones/Fluoroquinolones: Inhibit DNA gyrase, blocking DNA replication; used for urinary tract infections and pneumonia.

• Polymyxin B: Disrupts plasma membranes of Gram-negative bacteria; used topically.

• Sulfonamides: Competitive inhibitors of folic acid synthesis; structurally similar to PABA (para-aminobenzoic acid).

Laboratory Tests to Guide Chemotherapy

Methods for Determining Drug Effectiveness

• Disk diffusion (Kirby-Bauer) test: Measures the zone of inhibition around antibiotic-impregnated disks on an agar plate.

• Broth dilution test: Determines the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of an antibiotic.

Effects of Drug Combinations

Interactions Between Drugs

• Synergism: The combined effect of two drugs is greater than the effect of either drug alone.

• Antagonism: The combined effect of two drugs is less than the effect of either drug alone.

Mechanisms of Microbial Resistance

How Microbes Become Resistant

• Enzymatic destruction or inactivation of the drug (e.g., β-lactamases).

• Prevention of drug penetration to the target site.

• Alteration of the drug's target site.

• Rapid efflux (ejection) of the drug from the cell.

Antibiotic Misuse and Resistance

• Using outdated or weakened antibiotics.

• Using antibiotics for viral infections (e.g., common cold).

• Using antibiotics in animal feed.

• Failing to complete the prescribed regimen.

• Using someone else's leftover prescription.

Prevention of Antibiotic Resistance

• Always finish the prescribed regimen.

• Never use leftover antibiotics.

• Avoid unnecessary prescriptions.

• Use specific antibiotics rather than broad-spectrum agents when possible.

• Correct choice and dosage are essential.

Future of Chemotherapeutic Agents

Emerging Strategies

• Development of antimicrobial peptides.

• Phage therapy (using bacteriophages to target bacteria).

• Advances in understanding microbial genetics to design targeted therapies.